Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Cholest-4-en-3-one, oxime

EU orphan designation number: EU/3/06/397
Active ingredient: Cholest-4-en-3-one, oxime
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: Trophos SA
Parc scientifique de Lumigny, Case 931, Luminy Biotech Entreprise, F-13288 Marseille CEDEX 09, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2006 Centralised Orphan - Designation EMEA/OD/030/06 (2006)3925 of 28/08/2006
11/12/2012 Centralised Orphan - Removal of orphan designation from Community Register